Benjamin Davidson , Kristiana Xhima , Rees Cosgrove , Clement Hamani , Renana Eitan , Ali Rezai , Suzanne LeBlang , Noah S. Philip , Nir Lipsman
{"title":"聚焦超声在精神病学应用的路线图:2024年聚焦超声在精神病学研讨会论文集(FUS-PULSE)","authors":"Benjamin Davidson , Kristiana Xhima , Rees Cosgrove , Clement Hamani , Renana Eitan , Ali Rezai , Suzanne LeBlang , Noah S. Philip , Nir Lipsman","doi":"10.1016/j.brs.2025.08.012","DOIUrl":null,"url":null,"abstract":"<div><div>Transcranial focused ultrasound (FUS) is an emerging neuromodulation modality that enables incisionless, spatially precise targeting of deep brain structures implicated in neuropsychiatric conditions. Growing clinical applications in FUS psychiatry encompass both transient and permanent bioeffects, including focal lesioning, neurostimulation, and targeted drug delivery.</div><div>In response to rapid advances in the field, an in-person multidisciplinary symposium, FUS-PULSE, was held in Toronto, Canada from June 5–7 2024. The meeting convened over 70 international experts across neurosurgery, psychiatry, neurology, psychology, radiology, neuroimaging, physics, and industry to evaluate critical challenges and chart a strategic path forward for the field of FUS psychiatry.</div><div>Key themes from FUS-PULSE are highlighted, including the need to integrate circuit-based precision psychiatry, navigating the evolving landscape of FUS devices and parameters, and advancing clinical applications across lesioning, neuromodulation, and drug delivery.</div><div>FUS-based interventions can complement existing behavioral, pharmacological and neuromodulatory treatments to expand options for patients with refractory psychiatric conditions. However, significant barriers remain in optimizing the technology including treatment parameters and developing clinical protocols. The field must prioritize standardized reporting methodologies, protocol harmonization and real-time monitoring of target engagement. High-intensity FUS lesioning, particularly targeting the anterior limb of the internal capsule, shows promise for major depressive disorder and obsessive-compulsive disorder. Advancements in microbubble-assisted lesioning techniques and target mapping for optimal clinical response will further expand targeting possibilities and improve treatment efficacy. FUS neuromodulation and drug delivery applications remain at an early stage of development with promising potential. A deeper understanding of bioeffects across devices, parameters, and brain targets will be critical for successful clinical translation.</div></div>","PeriodicalId":9206,"journal":{"name":"Brain Stimulation","volume":"18 5","pages":"Pages 1651-1662"},"PeriodicalIF":8.4000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A roadmap for focused ultrasound applications in psychiatry: Proceedings of the 2024 symposium on focused ultrasound in psychiatry (FUS-PULSE)\",\"authors\":\"Benjamin Davidson , Kristiana Xhima , Rees Cosgrove , Clement Hamani , Renana Eitan , Ali Rezai , Suzanne LeBlang , Noah S. Philip , Nir Lipsman\",\"doi\":\"10.1016/j.brs.2025.08.012\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Transcranial focused ultrasound (FUS) is an emerging neuromodulation modality that enables incisionless, spatially precise targeting of deep brain structures implicated in neuropsychiatric conditions. Growing clinical applications in FUS psychiatry encompass both transient and permanent bioeffects, including focal lesioning, neurostimulation, and targeted drug delivery.</div><div>In response to rapid advances in the field, an in-person multidisciplinary symposium, FUS-PULSE, was held in Toronto, Canada from June 5–7 2024. The meeting convened over 70 international experts across neurosurgery, psychiatry, neurology, psychology, radiology, neuroimaging, physics, and industry to evaluate critical challenges and chart a strategic path forward for the field of FUS psychiatry.</div><div>Key themes from FUS-PULSE are highlighted, including the need to integrate circuit-based precision psychiatry, navigating the evolving landscape of FUS devices and parameters, and advancing clinical applications across lesioning, neuromodulation, and drug delivery.</div><div>FUS-based interventions can complement existing behavioral, pharmacological and neuromodulatory treatments to expand options for patients with refractory psychiatric conditions. However, significant barriers remain in optimizing the technology including treatment parameters and developing clinical protocols. The field must prioritize standardized reporting methodologies, protocol harmonization and real-time monitoring of target engagement. High-intensity FUS lesioning, particularly targeting the anterior limb of the internal capsule, shows promise for major depressive disorder and obsessive-compulsive disorder. Advancements in microbubble-assisted lesioning techniques and target mapping for optimal clinical response will further expand targeting possibilities and improve treatment efficacy. FUS neuromodulation and drug delivery applications remain at an early stage of development with promising potential. A deeper understanding of bioeffects across devices, parameters, and brain targets will be critical for successful clinical translation.</div></div>\",\"PeriodicalId\":9206,\"journal\":{\"name\":\"Brain Stimulation\",\"volume\":\"18 5\",\"pages\":\"Pages 1651-1662\"},\"PeriodicalIF\":8.4000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Brain Stimulation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1935861X25003055\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain Stimulation","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1935861X25003055","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
A roadmap for focused ultrasound applications in psychiatry: Proceedings of the 2024 symposium on focused ultrasound in psychiatry (FUS-PULSE)
Transcranial focused ultrasound (FUS) is an emerging neuromodulation modality that enables incisionless, spatially precise targeting of deep brain structures implicated in neuropsychiatric conditions. Growing clinical applications in FUS psychiatry encompass both transient and permanent bioeffects, including focal lesioning, neurostimulation, and targeted drug delivery.
In response to rapid advances in the field, an in-person multidisciplinary symposium, FUS-PULSE, was held in Toronto, Canada from June 5–7 2024. The meeting convened over 70 international experts across neurosurgery, psychiatry, neurology, psychology, radiology, neuroimaging, physics, and industry to evaluate critical challenges and chart a strategic path forward for the field of FUS psychiatry.
Key themes from FUS-PULSE are highlighted, including the need to integrate circuit-based precision psychiatry, navigating the evolving landscape of FUS devices and parameters, and advancing clinical applications across lesioning, neuromodulation, and drug delivery.
FUS-based interventions can complement existing behavioral, pharmacological and neuromodulatory treatments to expand options for patients with refractory psychiatric conditions. However, significant barriers remain in optimizing the technology including treatment parameters and developing clinical protocols. The field must prioritize standardized reporting methodologies, protocol harmonization and real-time monitoring of target engagement. High-intensity FUS lesioning, particularly targeting the anterior limb of the internal capsule, shows promise for major depressive disorder and obsessive-compulsive disorder. Advancements in microbubble-assisted lesioning techniques and target mapping for optimal clinical response will further expand targeting possibilities and improve treatment efficacy. FUS neuromodulation and drug delivery applications remain at an early stage of development with promising potential. A deeper understanding of bioeffects across devices, parameters, and brain targets will be critical for successful clinical translation.
期刊介绍:
Brain Stimulation publishes on the entire field of brain stimulation, including noninvasive and invasive techniques and technologies that alter brain function through the use of electrical, magnetic, radiowave, or focally targeted pharmacologic stimulation.
Brain Stimulation aims to be the premier journal for publication of original research in the field of neuromodulation. The journal includes: a) Original articles; b) Short Communications; c) Invited and original reviews; d) Technology and methodological perspectives (reviews of new devices, description of new methods, etc.); and e) Letters to the Editor. Special issues of the journal will be considered based on scientific merit.